Ertapenem

This page contains recent news articles, when available, and an overview of Ertapenem but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

… Approves New Indication for INVANZ(R) (ertapenem) for the Treatment...  -  Nov 14, 2005
WHITEHOUSE STATION, NJ -- Merck & Co., Inc. announced today that the US Food and Drug Administration (FDA) has approved INVANZ(R) (ertapenem), a once-daily ... Free with registration - Business Wire - AccessMyLibrary.com

Ertapenem (Systemic).  -  Feb 1, 2006
Ertapenem (er-ta-PEN-em) is used in the treatment of infections caused by bacteria. It works by killing bacteria or preventing their growth. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

FDA approves new indication for Invanz (ertapenem) for the prevention...  -  Dec 20, 2006
Merck & Co Inc announced that the US Food and Drug Administration (FDA) recently approved Invanz (ertapenem), a once-daily injectable antibiotic, ... Pay-Per-View - Company Reports - Factiva, from Dow Jones

Once-daily ertapenem good for diabetic foot infections.(Clinical...  -  Mar 1, 2005
WASHINGTON -- Once-daily treatment with ertapenem was as safe and effective as a four-times-daily regimen with two other antibiotics for diabetic patients ... Free with registration - Skin & Allergy News - AccessMyLibrary.com

Invanz: ertapenem for injection.(New indications)(Drug overview)  -  Feb 1, 2007
MERCK Ertapenem, a sterile, synthetic, parenteral, 1-beta methyl-carbapenem, is structurally related to beta-lactam antibiotics. This agent has demonstrated ... $4.95 - Formulary - ECNext

… Approves New Indication For INVANZ® (ertapenem) For The Prevention...  -  Dec 28, 2006
Merck & Co., Inc. announced today that the US Food and Drug Administration (FDA) recently approved INVANZ® (ertapenem), a once-daily injectable antibiotic, ... Medical News Today - Medical News Today (press release)

Ertapenem resistance of Escherichia coli.(DISPATCHES)(Clinical report)  -  Feb 1, 2007
An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. $4.95 - Emerging Infectious Diseases - ECNext

Merck receives US FDA approval for ertapenem  -  Dec 26, 2006
Merck & Co., Inc. has announced that the US Food and Drug Administration (FDA) recently approved Invanz (ertapenem). It is a once-daily injectable ... pharmabiz.com

Merck Recalls 3 Lots of Invanz (ertapenem sodium) Injection Because...  -  Jul 5, 2007
BETHESDA, MD -- July 5, 2007 -- Merck and US Food and Drug Administration (FDA) informed healthcare professionals that three lots of Invanz (0803930, ... DG News

Ertapenem effective for diabetic foot infections: once-daily ertapenem...  -  Feb 15, 2005
WASHINGTON -- Once-daily treatment with ertapenem was as safe and effective as a four-times daily regimen with two other antibiotics for treating diabetic ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones

ertapenem Merck & Co marketed, Hong Kong, Estonia (bacterial infection...  -  Jan 10, 2005
...ertapenem, ertapenem sodium, entrapenem, MK 826, MK 0826, L 749345, ZD 4433, INVANZ, J1P, Other Betalactam Antibacterials, Merck & Co, marketed, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

… ; Patients with intraabdominal infections effectively treated with...  -  Apr 12, 2006
According to a study from Germany, "Ertapenem, a class 1 carbapenem, ... Patients received 1 g of ertapenem intravenously for perioperative prophylaxis. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Ertapenem effective for diabetic foot infection: response to the...  -  Feb 1, 2005
Ertapenem effective for diabetic foot infection: response to the single drug was similar to that of the combination of piperacillin and tazobactam. Pay-Per-View - Family Practice News - HighBeam Research

Antibiotic gets new indication.(LATEBREAKERS)(Ertapenem)(Brief...  -  Jan 22, 2007
Ertapenem (Invanz, Merck) can now be used for the prophylaxis of surgical site infections following elective colorectal surgery. ... $4.95 - Drug Topics - ECNext

Article: Once-daily ertapenem good for diabetic foot infections.(Clini...  -  Mar 1, 2005
Once-daily ertapenem good for diabetic foot infections.(Clinical Rounds) ... find Skin & Allergy News articles. WASHINGTON -- Once-daily treatment with ... Pay-Per-View - Skin & Allergy News - HighBeam Research

The injectable antibiotic ertapenem (Invanz, Merck) was approved by...  -  Dec 1, 2005
The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections due to indicated pathogens ... Free with registration - Formulary - AccessMyLibrary.com

Merck Antibiotic Approved in US  -  Dec 22, 2006
A second adequate and well-controlled study to confirm these findings has not been conducted; therefore, the clinical superiority of ertapenem over ... RedOrbit

… : Ertapenem effective for diabetic foot infections: once-daily...  -  Feb 15, 2005
Ertapenem effective for diabetic foot infections: once-daily ertapenem was as safe and effective as two other antibiotics given four times per day. Pay-Per-View - Internal Medicine News - HighBeam Research

香港�?家醫生濫用抗生素較醫管局醫院高764�?  -  Jun 24, 2008
...學會會長蘇曜�?�表示，Ertapenem是抗生素中的“�?型炮彈�?，�?應經常使用，若使用�?當，令細�?�抗藥性�?題更嚴�?，原有病毒則無藥�?�治。蘇曜�?�稱，衛生署建議此藥隻�?�在腸 ... 人民网

Ertapenem 強效治腹腔感染  -  Jun 24, 2008
...�?明報專訊】Ertapenem是一種屬於Carbapenem類強�?抗生素（�?劑型），03年6月在港註冊，是衛生署�?�?�治療腹內感染�?皮膚感染�?尿�?�感染等中度至嚴�?症的藥物，�?�時亦 ... 香港新浪網

The injectable antibiotic ertapenem (Invanz, Merck) was approved by...  -  Dec 1, 2005
The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections due to indicated pathogens ... $4.95 - Formulary - ECNext

Federal Register 2006 - 71 FR 62595 Pediatric Advisory Committee; …  -  Oct 26, 2006
...on adverse event reports for ertapenem (INVANZ), gemcitabine (GEMZAR), glimepiride (AMARYL), insulin aspart recombinant (NOVOLOG), linezolid (ZYVOX), ... Pay-Per-View - Federal Register 2006 - Loislaw

The injectable antibiotic ertapenem (Invanz, Merck) was approved by...  -  Dec 1, 2005
The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections. ... $9.94 - Formulary - Alacra Store

Comparison of prophylactic antibiotics in colorectal surgery.(EVIDENCE...  -  Apr 1, 2007
Ertapenem is a carbapenem antibiotic used in the treatment of ... The results of this study revealed that prophylaxis with ertapenem was superior to ... $4.95 - AORN Journal - ECNext

Article: New indication for Invanz.(PRODUCTS)(Brief article) -...  -  Apr 1, 2007
...find Internal Medicine News articles. Invanz (ertapenem), a once-daily injectable antibiotic, has been approved for the prevention of surgical site... Pay-Per-View - Internal Medicine News - HighBeam Research

Drug Approvals  -  Nov 15, 2005
The FDA has approved Merck's Invanz (ertapenem), a once-daily injectable antibiotic, for the treatment of moderate to severe complicated foot infection due ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones

E coli urinary isolates likely multi-drug resistant: researchers...  -  Mar 1, 2006
In contrast, the resistance rate was 0% for ertapenem, 4% for nitrofurantoin, and 8.8% for cefdinir. Among 1017 isolates that demonstrated concomitant ... $4.95 - Urology Times - ECNext

FDA Approvals: Exjade, Oncaspar, Invanz  -  Nov 17, 2005
On Oct. 14, the FDA approved a new indication for once-daily ertapenem injection (Invanz, ... In the study, patients received either ertapenem, 1 g daily, ... Medscape

香港�?家医生滥用抗生素较医管局医院高764�?  -  Jun 24, 2008
...学会会长�?曜�?�表示，Ertapenem是抗生素中的“�?型炮弹�?，�?应�?常使用，若使用�?当，令细�?�抗�?�性问题更严�?，原有病毒则无�?��?�治。 �?曜�?�称，�?�生署建议此�?��?��?�在肠 ... 中新网

Ertapenem approvato per il piede diabetico  -  Nov 15, 2005
Disco verde della Food and Drug Administration Usa per l'antibiotico iniettabile Invanz* (ertapenem), per il trattamento delle infezioni ai piedi associate ... Pharma Marketing

IDSA releases guidelines for the diagnosis and treatment of skin and...  -  Oct 1, 2006
Patients who are not allergic to penicillin should receive oral amoxicillin/clavulanate (Augmentin), intravenous ampicillin/sulbactam (Unasyn), or ertapenem ... Free with registration - American Family Physician - AccessMyLibrary.com

Press Release: New Data Show In Vitro Potency of Doripenem Against …  -  Oct 27, 2008
Similarly, doripenem, imipenem and ertapenem inhibited the growth of >90% of CIPRE at concentrations of 0.5 micrograms/mL, 1 micrograms/mL, ... Pay-Per-View - PR Newswire - HighBeam Research

Prevención del pie diabético y mutilaciones relacionadas centra la …  -  Nov 6, 2005
Afortunadamente hoy en día gozamos de nuevos antibióticos, de nueva generación, como el Ertapenem que cubre la gran mayoría de los gérmenes que se asocian a ... El Observador - El Observador (Venezuela)

Johnson & Johnson Pharmaceutical Research & Development reports …  -  Oct 28, 2008
Similarly, doripenem, imipenem and ertapenem inhibited the growth of >90% of CIPRE at concentrations of 0.5 micrograms/mL, 1 micrograms/mL, ... $9.94 - M2 Europharma - Alacra Store

IDSA releases guidelines for the diagnosis and treatment of skin and...  -  Oct 1, 2006
Patients who are not allergic to penicillin should receive oral amoxicillin/clavulanate (Augmentin), intravenous ampicillin/sulbactam (Unasyn), or ertapenem ... $4.95 - American Family Physician - ECNext

… efficacy of a once-daily dose of tigecycline vs ertapenem in...  -  Dec 1, 2007
This purpose of this study is to look at the safety and effectiveness of a once-daily dose of tigecycline compared to ertapenem for the treatment of ... $4.95 - Journal of Drugs in Dermatology - ECNext

Federal Register 2006 - 71 FR 5667 Summaries of Medical and Clinical ...  -  Feb 2, 2006
...reviews of pediatric studies submitted in supplements for INVANZ (ertapenem), KEPPRA (levetiracetam), TRILEPTAL (Oxcarbazepine), and ZYVOX (linezolid). ... Pay-Per-View - Federal Register 2006 - Loislaw

Mupirocin Resistance May Be Common in MRSA Clinical Isolates  -  Jul 21, 2008
A ventilator-associated pneumonia protocol implemented in 2005 involved antimicrobial cycling and de-escalation (imipenem to ertapenem, cefepime to ... Medscape

New drug to beat smoking approved.  -  Jan 16, 2007
Ertapenem, although initially more expensive than drugs currently available, can be used once a day and is more convenient to patients. ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

Community-acquired pneumonia.(Clinical Guidelines For Family …  -  Sep 15, 2007
Ertapenem may be used in patients with risks for anaerobic and drug resistant S. pneumoniae infections. * In these patients, use a [beta]-lactam (cefotaxime ... Free with registration - Family Practice News - AccessMyLibrary.com

Amp C -lactamase-producing Escherichia coli in neonatal meningitis: …  -  Feb 16, 2006
Carbapenems with activity against AmpC -lactamases include imipenem, meropenem and the newer agent, ertapenem. 16 Imipenem-cilastatin is not recommended for ... Nature.com

A Morbilliform Variant of Vancomycin-Induced Linear IgA Bullous …  -  Aug 25, 2007
Clinically, the dermatology service favored the diagnosis of a morbilliform drug eruption caused by ertapenem or vancomycin. We believed that the purpura of ... Archives of Dermatology

Antibiotic and Antiviral Drug Classes  -  Apr 14, 2008
Carbapenems include meropenem (Merrem), biapenem, faropenem, ertapenem (Invanz) and combinations (imipenem/cilastatin [Primaxin]). These agents cover a wide ... New York Times

Ann Intern Med -- Rapid Responses for Wachter et al., 149 (1) 29-32  -  Aug 18, 2008
...physicians at Dixie Regional Medical Center (St. George, Utah) to rewrite the local guideline to include CMS accepted antibiotics such as ertapenem. ... Annals of Internal Medicine

Handbook on Injectable Drugs – 14th Edition  -  Feb 4, 2008
...amphotericin B lipid complex, amphotiracin B liposomal, anakinra, antithymocyte globin rabbit, daptomycin, drotrecogin alfa, ertapenem, gallium nitrate, ... Medscape

Replidyne Pipeline Featured at 47th Annual Interscience Conference on...  -  Sep 17, 2007
Faropenem Presentations Monday, September 17 at 12:00 PM, Hall D: -- Poster E-256, titled "Comparison of the Bactericidal Activities of Faropenem, Ertapenem ... Free with registration - PR Newswire - AccessMyLibrary.com

Article: Antibiotic against superbugs is delayed.(Stock price)(Brief...  -  Apr 7, 2008
Journal of Drugs in Dermatology; December 1, 2007 ; 604 words ... ... tigecycline compared to ertapenem for the treatment of diabetic foot infections. ... Pay-Per-View - Chemistry and Industry - HighBeam Research

FDA Issues MedWatch Alerts for Two Injectable Antibiotics  -  Jul 13, 2007
Merck July 2 sent “Dear Healthcare Provider�? letters to inform customers that 75000 vials of Invanz (ertapenem) had been recalled due to reports of glass ... FDA news - FDA news (subscription)

Company Profile Report  -  Apr 5, 2008
Invanz (Ertapenem Sodium). Diabetic Nephropathy. Angiotensin II Receptor Antagonists. Products:. Cozaar (Losartan Potassium). Non-Insulin Dependent Diabetes ... $50.00 - Revere Reports - Revere

VIM-2-producing Pseudomonas putida, Buenos Aires.(Letter to the...  -  Apr 1, 2007
VIM-2]-carrying Pseudomonas putida isolates, Argentina MIC ([micro]g/mL) Drug Isolate 1 Isolate 2 Imipenem 32 64 Meropenem 64 64 Ertapenem 128 128 ... Free with registration - Emerging Infectious Diseases - AccessMyLibrary.com

INVANZ approved for complicated foot infection in diabetic patients.(...  -  Feb 1, 2006
Merck & Co., Inc., recently announced that the FDA has approved INVANZ (ertapenem), a once-daily injectable antibiotic, for the treatment of moderate to ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

Press Release: Carbapenem Drug Class Shows an Increase in Hospital …  -  Nov 6, 2008
...followed by AstraZeneca's Merrem/Meronem (meropenem) (36 percent) and Merck's Invanz (ertapenem injectable) (10 percent)," stated Joyce Wedemeyer, ... Pay-Per-View - PR Newswire - HighBeam Research

Invanz Recall  -  Jul 10, 2007
Merck is informing health care providers that 3 lots (0803930, 0803940, and 0803950) of Invanz (ertapenem), have been recalled due to 2 reports of broken ... Facts and Comparisons

Management of skin infections.(THE EFFECTIVE PHYSICIAN)(Disease/ …  -  Apr 1, 2006
Most patients should be treated with oral amoxicillin-clavulanate, intravenous ampicillin-sulbactam, or ertapenem. Human bites cause polymicrobial ... Free with registration - Internal Medicine News - AccessMyLibrary.com

EMEA Adopts Positive Opinion On Neupro (Parkinson's Disease) And …  -  Dec 17, 2005
Invanz (ertapenem), Merck Sharp & Dohme, to extend its indication to add diabetic foot infections of the skin and soft tissue. Invanz was first authorised ... Medical News Today - Medical News Today (press release)

Afternoon colonoscopies versus morning colonoscopies.(EVIDENCE …  -  Apr 1, 2007
Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med. 2006;355:2640-2651. (3.) Correll DJ, Bader AM, Hull MW, Hsu C, Tsen LC, ... Free with registration - AORN Journal - AccessMyLibrary.com

Navigating the latest pneumonia guidelines  -  Oct 9, 2007
One antibiotic has been added to the recommendations: ertapenem, a carbapenem now listed among alternatives for hospitalized patients at high risk for ... Clinical Advisor

Merck launches restructuring  -  Dec 5, 2005
The company is aiming to sell rather than shutter its Cherokee site in Danville, Pa., which makes APIs include avermectin, asparaginase and ertapenem sodium ... ICIS

Once-Daily IV Antibiotic Effective for Diabetic Foot Infections  -  Nov 10, 2005
11 - Invanz (ertapenem) is as effective as Zosyn (piperacillin/tazobactam) for diabetic foot infections but has the convenience of once-daily dosing, ... MedPage Today

Merck's Invanz gains FDA approval for treatment of foot infections.  -  Nov 28, 2005
US drug major Merck & Co says the Food and Drug Administration has approved Invanz (ertapenem), the firm's once-daily injectable antibiotic, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

高平�?展旺�?�竹科產學�?�作�?�助  -  Mar 5, 2008
...�?��?�?�製程技術開發�?研發案，�?�243�?�元�?�助。伊特培�?�（Ertapenem）是一種新型的carbapenem類抗生素藥物，被應用於治療由需氧�?��?厭氧�?�混�?�感染的新�?有效治療劑。 udn.com

Enterobacteriaceae Outbreaks; CTX-M-1-producing Enterobacteriaceae …  -  Oct 24, 2006
...and >32 mcg/mL for imipenem, meropenem, and ertapenem, respectively) was documented, both in clinical samples and in intestinal colonization studies. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Papel de las bacterias grampositivas en la infección intraabdominal  -  Jan 17, 2008
El papel, en esas circunstancias, de fármacos como linezolid, ertapenem, tigeciclina y daptomicina está todavía poco estudiado. ... doyma.es

Guidelines for managing hospital-acquired pneumonia.(CLINICAL …  -  Jun 1, 2005
...for initial empiric therapy include ceftriaxone, a fluoroquinolone (levofloxacin, moxifloxacin, ciprofloxacin), ampicillin/ sulbactam, or ertapenem. ... $4.95 - Journal of Respiratory Diseases - ECNext

Invanz.(NEW INDICATION)(Brief article)  -  Jan 22, 2007
FDA has granted to Merck & Co., Whitehouse Station, NJ, (908) 423-1000, a new indication for Invanz (ertapenem). The injectable antibiotic is now indicated ... $4.95 - Drug Topics - ECNext

New Jersey Administrative Code - 10:58A-4.3 HCPCS procedure codes …  -  Aug 16, 2005
...per 2 mg 428.00 (Zometa) C9116 Injection, ertapenem sodium, per 1 gram 49.98 vial C9120 Injection, fulvestrant, per 50 mg 184.38 C9121 Injection, ... Pay-Per-View - New Jersey Administrative Code - Loislaw

KPC type [beta]-lactamase, rural Pennsylvania.(Letter to the editor)  -  Oct 1, 2006
The patient received therapy with amikacin in combination with cefepime, ertapenem, or tigecycline at different times over the following 4 weeks. ... $4.95 - Emerging Infectious Diseases - ECNext

New indication for avandia.(PRODUCTS)(Brief Article) | Article from …  -  May 1, 2005
Invanz (ertapenem), a once-daily injectable antibiotic, has been approved for the prevention of surgical site infections after elective colorectal surgery ... Pay-Per-View - Internal Medicine News - HighBeam Research

Diabetes Complications; US FDA approves INVANZ for treatment …  -  Dec 13, 2005
2005 DEC 13 - (NewsRx.com) -- Merck & Co., Inc. announced that the US Food & Drug Administration (FDA) has approved INVANZ (ertapenem), a once-daily ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Antimicrobial drug resistance in Singapore hospitals.(DISPATCHES)( …  -  Dec 1, 2007
Ertapenem resistance was reported in 0.2% of all E. coli isolates and 0.9% of all K. pneumoniae isolates at the institutions that routinely test for this ... $4.95 - Emerging Infectious Diseases - ECNext

Clinical News: Scottish Medicines Consortium approvals.  -  Oct 13, 2007
The Consortium has also approved ertapenem (Invanz, MSD) in preventing surgical site infection following colorectal surgery, and the formoterol inhaler ... $9.94 - Chemist & Druggist - Alacra Store

EBSCOhost Connection: News from the FDA.  -  Jan 1, 2006
These include Enlafaxine which was approved for the treatment of adults with panic disorder and Ertapenem which was approved for the treatment of moderate ... Subscription - Patient Care for the Nurse Practitioner - EBSCO Publishing

Enterobacteriaceae Outbreaks; CTX-M-1-producing Enterobacteriaceae …  -  Oct 25, 2006
...and >32 mcg/mL for imipenem, meropenem, and ertapenem, respectively) was documented, both in clinical samples and in intestinal colonization studies. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

VIM-2-producing Pseudomonas putida, Buenos Aires.(Letter to the...  -  Apr 1, 2007
VIM-2]-carrying Pseudomonas putida isolates, Argentina MIC ([micro]g/mL) Drug Isolate 1 Isolate 2 Imipenem 32 64 Meropenem 64 64 Ertapenem 128 128 ... $4.95 - Emerging Infectious Diseases - ECNext

Multidrug-resistant bacteria in southeastern Austria.(enterobacteriace...  -  Aug 1, 2007
...showed reduced susceptibility to imipenem (MIC 2 [micro]g/mL) and to meropenem (MIC 4 [micro]g/mL) and resistance to ertapenem (MIC >16 [micro]g/mL). ... $4.95 - Emerging Infectious Diseases - ECNext

Article: Diabetic foot infections: learnings and ambitions.(Clinical...  -  Sep 22, 2007
Journal of Drugs in Dermatology; December 1, 2007 ; 604 words ... ... tigecycline compared to ertapenem for the treatment of diabetic foot infections. ... Pay-Per-View - Diabetic Foot - HighBeam Research

Clinical News: Scottish Medicines Consortium approvals.(Brief article)  -  Oct 13, 2007
The Consortium has also approved ertapenem (Invanz, MSD) in preventing surgical site infection following colorectal surgery, and the formoterol inhaler ... $4.95 - Chemist & Druggist - ECNext

Data find increase in UTIs caused by ESBL-E coli: hospitalization, …  -  Mar 1, 2006
..."In those areas, parenteral therapy with carbapenems (Meropenem, Imipenem, or Ertapenem) constitute the first choice when empirical treatment is required ... $4.95 - Urology Times - ECNext

Invanz.  -  Jan 22, 2007
FDA has granted to Merck & Co., Whitehouse Station, N.J., (908) 423-1000, a new indication for Invanz (ertapenem). The injectable antibiotic is now ... $9.94 - Drug Topics - Alacra Store

Antibiotic panel for Streptococcus pneumoniae.(Answering your …  -  Apr 1, 2005
Amoxicillin, ampicillin, cefepime, cefotaxime, ceftriaxone, cefuroxime, ertapenem, imipenem, and meropenem must be tested by a MIC method. ... $4.95 - Medical Laboratory Observer - ECNext

Factiva Search  -  Dec 27, 2006
The FDA has approved Merck's Invanz (ertapenem), a once-daily injectable antibiotic, for the prophylaxis of surgical ... ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones

Diabetic foot infections: learnings and ambitions.(Clinical report)  -  Sep 22, 2007
...three of which are now FDA approved specifically for diabetic foot infection (linezolid, ertapenem, and piperacillin/tazobactam; Lipsky et al, 2004b; ... $4.95 - Diabetic Foot - ECNext

New indication for Zemplar.(PRODUCTS)(Brief Article) | Article from …  -  Oct 1, 2005
Invanz (ertapenem), a once-daily injectable antibiotic, has been approved for the prevention of surgical site infections after elective colorectal surgery ... Pay-Per-View - Internal Medicine News - HighBeam Research

Article: Diabetic foot infection: dispelling the myths.(Guest...  -  Mar 22, 2005
Journal of Drugs in Dermatology; December 1, 2007 ; 604 words ... ... tigecycline compared to ertapenem for the treatment of diabetic foot infections. ... Pay-Per-View - Diabetic Foot - HighBeam Research

Merck & Co returns to India.(pharmaceuticals)(Brief Article)  -  Aug 1, 2005
Merck also has four products under registration in India: the antibiotic Invanz (ertapenem), the antifungal Cancidas (caspofungin) and two vaccines, ... $4.95 - Pharma Marketletter - ECNext

New indication for Invanz.(PRODUCTS)(Brief article)  -  Apr 1, 2007
Invanz (ertapenem), a once-daily injectable antibiotic, has been approved for the prevention of surgical site infections after elective colorectal surgery ... $4.95 - Internal Medicine News - ECNext

Bordetella petrii clinical isolate.(DISPATCHES)  -  Jul 1, 2005
...>256 Piperacillin/tazobactam 2 Ceftriaxone >32 Cefotaxime >32 Ceftazidime 32 Imipenem >32 Meropenem >32 Ertapenem >32 Amikacin >256 ... $4.95 - Emerging Infectious Diseases - ECNext

İlaç ve tedaviye ilişkin Maliye genelgesi  -  Mar 26, 2008
...“Ertapenem�? etken maddesi, (EK-2/A Madde 35.1'e göre) ile. 43. “Gatifloksasin oftalmik formları�?, (EK-2/A Madde 67.1'e göre) ... Memurlar

Revue de presse du Mercredi 8 juin 2005  -  Jun 8, 2005
Enfin, le CHMP recommande qu'Invanz® (ertapenem) de Merck MSD, utilisé pour le traitement d'infections bactériennes chez l'adulte (infections abdominales, ... Pharmaceutiques

Infecciones complejas: manejo quirúrgico y antibiótico (2º Parte)  -  Oct 10, 2007
Estos podrían incluir ampicilina-sulbactam, cefazolina o cefuroxima más metronidazol, ticarcilina-clavulanato, ertapenem y quinolonas más metronidazol. ... Intramed.net - Intramed.net (Suscripción)

Georgia Code - 16-13-71. (a) A "dangerous drug" means any drug other ...  -  Aug 4, 2005
...(346) Ergocorninine; (346.1) Erlotinib; (346.5) Ertapenem; (347) Erythrityl tetranitrate; (348) Erythromycin; (348.722) Escitalopram; (349) Eserine; ... Pay-Per-View - Georgia Code - Loislaw

Carbapenem resistance in Klebsiella pneumoniae not detected by …  -  Aug 1, 2006
Ertapenem Etest strips and disks were not tested in this study. This lack of consensus on reading Etest method, which is often used as a secondary testing ... $4.95 - Emerging Infectious Diseases - ECNext

Anidulafungin: an echinocandin antifungal for the treatment of...  -  Aug 1, 2006
The 3 medications with incompatibility that should not be co-infused with anidulafungin at the Y-site are amphotericin B, ertapenem, and sodium bicarbonate. ... $4.95 - Formulary - ECNext

Article: Pre-packaged microorganism cultures.(Product News) - …  -  Mar 1, 2007
Article: Ertapenem susceptibility of extended spectrum beta ... Annals of Clinical Microbiology and Antimicrobials; June 6, 2007 ; 700+ words . ... Pay-Per-View - Bioscience Technology - HighBeam Research

Negative pressure speeds diabetic foot ulcer healing.(Metabolic …  -  May 1, 2006
Article: Ertapenem effective for diabetic foot infection: ... Family Practice News; February 1, 2005 ; 700+ words ... ... evaluable patients. ... Pay-Per-View - Family Practice News - HighBeam Research

Infected or not?--Managing lesions of the diabetic foot.(Metabolic …  -  Sep 1, 2005
Article: Ertapenem effective for diabetic foot infection: ... Family Practice News; February 1, 2005 ; 700+ words ... ... trial of treatment of moderate to ... Pay-Per-View - Family Practice News - HighBeam Research

Symptoms key to detecting diabetic infections: surprisingly, culturing...  -  Sep 15, 2005
Article: Ertapenem effective for diabetic foot infections: ... Internal Medicine News; February 15, 2005 ; 700+ words ... ... evaluable patients. ... Pay-Per-View - Internal Medicine News - HighBeam Research

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.